MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Short Term Borrowings History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Borrowings | ₹639 Cr | ₹2,513 Cr | ₹151 Cr | ₹115 Cr | ₹795 Cr |
What is the latest Short Term Borrowings ratio of MANKIND PHARMA ?
| Year | Short Term Borrowings |
|---|---|
| Mar2026 | ₹639 Cr |
| Mar2025 | ₹2,513 Cr |
| Mar2024 | ₹151 Cr |
| Mar2023 | ₹115 Cr |
| Mar2022 | ₹795 Cr |
How is Short Term Borrowings of MANKIND PHARMA Trending?
| Years | Short Term Borrowings | % Change | |
|---|---|---|---|
| Mar2026 | ₹639 Cr | -74.58 | |
| Mar2025 | ₹2,513 Cr | 1,559.06 | |
| Mar2024 | ₹151 Cr | 31.70 | |
| Mar2023 | ₹115 Cr | -85.52 | |
| Mar2022 | ₹795 Cr | - | |
Compare Short Term Borrowings of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹97,253.2 Cr | -0.6% | 2.9% | -6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.6% |
2.9% |
-6% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses